These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38220088)

  • 1. Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Particles in Biopharmaceutical Products.
    Saggu M; Bou-Assaf GM; Bucher R; Budyak IL; Buecheler J; Cao S; Groenning M; Khan E; Kwok SC; Minocha S; Pisupati K; Radhakrishnan V; Videbæk N; Yang DT; Zhang B; Narhi LO
    J Pharm Sci; 2024 May; 113(5):1401-1414. PubMed ID: 38220088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
    Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
    J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of subvisible silicone oil droplets from irregular standard dust particles.
    Vandesteeg N; Kilbert C
    J Pharm Sci; 2013 Jun; 102(6):1696-1700. PubMed ID: 23595940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Subvisible Particles in Biotherapeutic Prefilled Syringes: The Role of Polysorbate and Protein on the Formation of Silicone Oil and Protein Subvisible Particles After Drop Shock.
    Jiao N; Barnett GV; Christian TR; Narhi LO; Joh NH; Joubert MK; Cao S
    J Pharm Sci; 2020 Jan; 109(1):640-645. PubMed ID: 31689431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle Characterization for a Protein Drug Product Stored in Pre-Filled Syringes Using Micro-Flow Imaging, Archimedes, and Quartz Crystal Microbalance with Dissipation.
    Zheng S; Puri A; Li J; Jaiswal A; Adams M
    AAPS J; 2017 Jan; 19(1):110-116. PubMed ID: 27620008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis.
    Corvari V; Narhi LO; Spitznagel TM; Afonina N; Cao S; Cash P; Cecchini I; DeFelippis MR; Garidel P; Herre A; Koulov AV; Lubiniecki T; Mahler HC; Mangiagalli P; Nesta D; Perez-Ramirez B; Polozova A; Rossi M; Schmidt R; Simler R; Singh S; Weiskopf A; Wuchner K
    Biologicals; 2015 Nov; 43(6):457-73. PubMed ID: 26324466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Syringe Age Prior to Filling on Migration of Subvisible Silicone-Oil Particles into Drug Product.
    Song J; Hu G; Hamzaoui H; Krishnamachari Y; Persak SC; Xi H; Su Y
    J Pharm Sci; 2022 Dec; 111(12):3191-3194. PubMed ID: 36404459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification and characterization of micrometer and submicrometer subvisible particles in protein therapeutics by use of a suspended microchannel resonator.
    Patel AR; Lau D; Liu J
    Anal Chem; 2012 Aug; 84(15):6833-40. PubMed ID: 22794526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
    Shah M; Rattray Z; Day K; Uddin S; Curtis R; van der Walle CF; Pluen A
    Int J Pharm; 2017 Mar; 519(1-2):58-66. PubMed ID: 28089934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of Silicone Oil and Its Degradation Products in Aqueous Pharmaceutical Formulations by
    Malmstrøm J
    J Pharm Sci; 2019 Apr; 108(4):1512-1520. PubMed ID: 30471289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Silicone Oil in Prefilled Syringes and Biopharmaceutical Drug Products Using High-Performance Liquid Chromatography.
    Liu J; Ronk M; Fujimori K; Lee H; Nashed-Samuel Y
    AAPS PharmSciTech; 2021 Feb; 22(2):75. PubMed ID: 33585996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Backgrounded Membrane Imaging (BMI) for High-Throughput Characterization of Subvisible Particles During Biopharmaceutical Drug Product Development.
    Helbig C; Ammann G; Menzen T; Friess W; Wuchner K; Hawe A
    J Pharm Sci; 2020 Jan; 109(1):264-276. PubMed ID: 30914272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variables Impacting Silicone Oil Migration and Biologics in Prefilled Syringes.
    Gentile K; Huang C; Liu X; Whitty-Léveillé L; Hamzaoui H; Cristofolli E; Rayfield W; Afanador NL; Mittal S; Krishnamachari Y; Xi H; Zhao X
    J Pharm Sci; 2023 Aug; 112(8):2203-2211. PubMed ID: 37244516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Cross-Linked Siliconized PFS Come to the Rescue of the Biologics Drug Product?
    Thakare V; Schmidt T; Rupprechter O; Leibold J; Stemmer S; Mischo A; Bhattacharjee D; Prazeller P
    J Pharm Sci; 2020 Nov; 109(11):3340-3351. PubMed ID: 32871152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introducing the Alba
    Chillon A; Pace A; Zuccato D
    PDA J Pharm Sci Technol; 2018; 72(4):382-392. PubMed ID: 29853611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Incremental Siliconization Levels on Soluble Aggregates, Submicron and Subvisible Particles in a Prefilled Syringe Product.
    Bai S; Landsman P; Spencer A; DeCollibus D; Vega F; Temel DB; Houde D; Henderson O; Brader ML
    J Pharm Sci; 2016 Jan; 105(1):50-63. PubMed ID: 26852839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstrating the stability of albinterferon alfa-2b in the presence of silicone oil.
    Auge KB; Blake-Haskins AW; Devine S; Rizvi S; Li YM; Hesselberg M; Orvisky E; Affleck RP; Spitznagel TM; Perkins MD
    J Pharm Sci; 2011 Dec; 100(12):5100-14. PubMed ID: 21780119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations.
    Ludwig DB; Trotter JT; Gabrielson JP; Carpenter JF; Randolph TW
    Anal Biochem; 2011 Mar; 410(2):191-9. PubMed ID: 21146492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress.
    Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF
    PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the siliconization method on particle generation in a monoclonal antibody formulation in pre-filled syringes.
    Gerhardt A; Nguyen BH; Lewus R; Carpenter JF; Randolph TW
    J Pharm Sci; 2015 May; 104(5):1601-9. PubMed ID: 25740412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.